Medical devices, healthcare technology and the business of care
510(k) clearance · K260631

Medican Alpha, Medican, Mediflon, Mediflon Quick, Medican Alpha Safety, Medican Safety, Mediflon Safety, Mediflon Safety Quick, Medican Alpha Safety Pro, Medican Safety Pro, Mediflon Safety Pro, Neocan, Enfancie, Neocan safety, Enfancie Safety

Global Medikit Limited · Decision date Nov 5, 2026

FDA DECISIONK260631

What did the FDA decide?

FDA records K260631 as a 510(k) premarket notification, with a decision dated Nov 5, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Nov 5, 2026

FDA source record

Regulatory record facts

Identifier
K260631
Regulatory pathway
510(k) premarket notification
Product code
FOZ
Decision code
SESE
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days.

Product code
FOZ
FDA device class
2

FDA decision timeline

  1. K260631 received

    Application receipt date recorded by FDA.

  2. K260631 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FOZ

Product / regulatory recordCompanyPathwayDecision dateSource
Venocare, Inc.510(k) clearanceSep 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Global Medikit Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Dehradun

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records